HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN

CHEBI:CHEBI_753012

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1365979
product_type
PLASMA DERIVATIVE
listing_expiration_date
20241231
route
INTRAMUSCULAR
dosage_form
INJECTION, SOLUTION
marketing_start_date
20190301
package_marketing_start_date
20190301
marketing_category
BLA
labeler_name
Saol Therapeutics
generic_name
HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN
active_ingredient_name
HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN
brand_name
VARIZIG
brand_name_base
VARIZIG
product_ndc
70257-126
application_number
BLA125430
spl_id
acfa976e-7b2c-4238-be60-dc597273c52a
active_ingredient_strength
125 [iU]/1.2mL
package_ndc
70257-126-51
package_description
1 VIAL, GLASS in 1 CARTON (70257-126-51) / 1.2 mL in 1 VIAL, GLASS (70257-126-11)
manufacturer_name
Saol Therapeutics
unii
33T61IWL27
spl_set_id
1cec80c5-a2b3-459f-959e-d6febfd2671c
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class